EUVIMEDEUVIMED entdecken
Multizentrische Studie

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib

Tarek Odah, Christian Karime, Aakash Desai, Michael F Picco, Jami A Kinnucan, Jana G Hashash, Francis A Farraye

Digestive Diseases and Sciences · 2024-10 · 69 (10) · 3911-3919

DOI: 10.1007/s10620-024-08630-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 09.09.2024. Verfasst von Tarek Odah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, 4500 San Pablo Rd S., Jacksonville, FL, 32224, USA. Odah…. Hauptthemen laut MEDLINE: Piperidines, Heterocyclic Compounds, 3-Ring, Pyrimidines, Colitis, Ulcerative. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesHeterocyclic Compounds, 3-RingPyrimidinesColitis, UlcerativeJanus Kinase InhibitorsCrohn DiseaseHumansFemaleMaleRetrospective StudiesAdultMiddle AgedTreatment OutcomeLeukocyte L1 Antigen Complex

Stichwörter der Autor:innen

Crohn’s diseaseInflammatory bowel diseaseTofacitinibUlcerative colitisUpadacitinib

Substanzen

upadacitinibtofacitinibPiperidinesHeterocyclic Compounds, 3-RingPyrimidinesJanus Kinase InhibitorsLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, 4500 San Pablo Rd S., Jacksonville, FL, 32224, USA. Odah.Tarek@mayo.edu.
  • Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Mayo Clinic, 4500 San Pablo Rd S., Jacksonville, FL, 32224, USA.

Zitieren

APA

Odah, T., Karime, C., Desai, A., Picco, M. F., Kinnucan, J. A., Hashash, J. G., & Farraye, F. A. (2024). Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib. Digestive Diseases and Sciences, 69(10), 3911-3919. https://doi.org/10.1007/s10620-024-08630-3

Vancouver

Odah T, Karime C, Desai A, Picco MF, Kinnucan JA, Hashash JG, et al. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib. Digestive Diseases and Sciences. 2024;69(10):3911-3919. doi:10.1007/s10620-024-08630-3

BibTeX
@article{Odah2024,
  author = {Odah, Tarek and Karime, Christian and Desai, Aakash and Picco, Michael F and Kinnucan, Jami A and Hashash, Jana G and Farraye, Francis A},
  title = {Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  volume = {69},
  number = {10},
  pages = {3911--3919},
  doi = {10.1007/s10620-024-08630-3}
}
Kostenlos starten →